Connect with us

Hi, what are you looking for?

Friday, Jun 25, 2021
Mugglehead Magazine
Cannabis & psychedelics industry news based in Vancouver, B.C.
  • Loading stock data...

Earnings

Canopy confident on profit prediction despite flat Q4 growth

Executives maintained that profits would show this fiscal year, despite weakening quarterly EBITDA and steep losses

Canopy confident on profit predictions despite flat Q4 growth
Image via Canopy

Executives at Canopy Growth Corp. (TSX: WEED) (Nasdaq: GCG) remain optimistic that the mega-firm will hit profitability targets this year, despite reporting sliding sales and hefty losses in their latest earnings report.

On Tuesday, the company reported net revenue of $148 million for its fiscal fourth quarter ended March 21, decreasing 3 per cent from $153 million in the previous quarter. The figure fell short of an average analyst prediction of $152 million, according to Yahoo Finance.

Net loss for the quarter came in at $617 million, driven by non-cash value adjustments of $292 million and impairment charges of $75 million. Net loss totalled $1.7 billion for fiscal 2021.

But in an earnings call with analysts Tuesday morning, comments from CEO David Klein indicated a sunny outlook, especially for operations in the United States.

“We remain committed to delivering positive adjusted EBITDA by the end of our fiscal [2022],” he said. “All eyes remain on the Senate as we expect Booker, Wyden and Schumer’s cannabis legalization bill to be introduced in the coming weeks and a potential vote before the end of the year.”

“Against that backdrop, we continue to lay the foundation and explore ways to further capitalize on the U.S. opportunity.”

If major cannabis legislation is passed, Canopy could close its deal to buy Acreage Holdings (CSE: ACRG.A.U) and possibly buy a bigger stake in TerrAscend (CSE: TER), which are both sizable multi-state operators.

However, experts are skeptical that the U.S. would legalize weed under the presidency of Joe Biden, despite bipartisan support for federal reform.

Read more: US cannabis banking likely to come ahead of Senate legalization bill

Read more: Canopy shares surge on 2022 profit prediction

Canopy confident on profit predictions despite flat Q4 growth - Martha Stewart

In May, Canopy welcomed wellness icon Martha Stewart as a strategic advisor. Press photo

In Canada, the firm says it’s made big progress in “right-sizing operations” — which include laying off over 1,000 employees and closing several facilities last year — stating fourth-quarter sales volume outpaced production by over 40 per cent.

CFO Mike Lee says overall flower volume increased 24 per cent, driven by more sales of 28-gram value packages and offset by declines in single-gram, 3.5-gram and 5-gram offerings.

Based on Canopy’s internal tracker, overall market share declined to 14.8 per cent in Q4. Lee said the company gained share in Ontario and lost share in British Columbia and Alberta. Share of flower sales increased to 19 per cent, maintaining the top spot.

Read more: Canadian weed sales bounce back to $298M in March

Read more: Can you buy brand loyalty? Canopy thinks so

Canopy says it captured the second-highest share in beverages with a 29.9 per cent share, and the number-two spot in edibles and extracts with 22 per cent.

The company reported adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) loss of $94 million, increasing 38 per cent from a loss of $68 million in Q3.

On Tuesday’s call, Bank of America analyst Heather Balsky asked how Canopy plans to bridge its current position to becoming EBITDA-positive by the end of the fiscal year.

Lee maintained that the pieces are in place to secure 40–50 per cent annual growth. According to him, those pieces include an increasing retail footprint in Canada, vast cuts to administrative and operational overheads, a diversified foothold in the U.S. as well as recent strategic acquisitions of premium brands Ace Valley and Supreme.

“Now we have the entire organization programmed against new operating budgets across the company,” he said. “And we simply need to adhere to those budgets and headcount plans, which we’re confident that we will do because we built the [organization] to really scale the right way.”

Canopy ended the quarter with $2.3 billion in cash and short-term investments, which Klein said would mostly go toward his firm’s U.S. endeavours.

Company stock fell over 3 per cent Tuesday to $29.33 on the Toronto Stock Exchange.

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Nick Laba on Twitter

nick@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Health and Safety

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can

News

Cannabis will be treated like alcohol under the company's policy changes

Enforcement

The legislation's steep penalties and confusing rules are a step backward to populations that have used cannabis traditionally for centuries

Canada

As more medium-to-small producers came into play this year, great weed started hitting legal shelves at fairer prices